"There's a sense of being strong-armed in to [the protocol] without being able to assess it properly."--Richard Frase, partner at Dechert, explaining why hedge funds are reluctant to sign up to the novations protocol.
"There's a sense of being strong-armed in to [the protocol] without being able to assess it properly."
